These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 12524581)
21. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD). Alaghband-Rad J; Hakimshooshtary M Eur Child Adolesc Psychiatry; 2009 Mar; 18(3):131-5. PubMed ID: 19190958 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorder. Zitterl W; Meszaros K; Hornik K; Twaroch T; Dossenbach M; Zitterl-Eglseer K; Zapotoczky HG Wien Klin Wochenschr; 1999 Jun; 111(11):439-42. PubMed ID: 10420495 [TBL] [Abstract][Full Text] [Related]
33. Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder. Leonard HL; Topol D; Bukstein O; Hindmarsh D; Allen AJ; Swedo SE J Am Acad Child Adolesc Psychiatry; 1994; 33(6):792-4. PubMed ID: 8083135 [TBL] [Abstract][Full Text] [Related]
34. Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial. Hoexter MQ; de Souza Duran FL; D'Alcante CC; Dougherty DD; Shavitt RG; Lopes AC; Diniz JB; Deckersbach T; Batistuzzo MC; Bressan RA; Miguel EC; Busatto GF Neuropsychopharmacology; 2012 Feb; 37(3):734-45. PubMed ID: 22030709 [TBL] [Abstract][Full Text] [Related]
35. Functional connectivity of the raphe nucleus as a predictor of the response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Kim M; Kwak S; Yoon YB; Kwak YB; Kim T; Cho KIK; Lee TY; Kwon JS Neuropsychopharmacology; 2019 Nov; 44(12):2073-2081. PubMed ID: 31189178 [TBL] [Abstract][Full Text] [Related]